![Dean's List - Spring 2017 | Enrollment Management, Marketing and Communications | Northern Illinois University Dean's List - Spring 2017 | Enrollment Management, Marketing and Communications | Northern Illinois University](https://www.niu.edu/emmc/_images/banners/spring-deans.jpg)
Dean's List - Spring 2017 | Enrollment Management, Marketing and Communications | Northern Illinois University
![Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus - Majumder - 2021 - Advanced Therapeutics - Wiley Online Library Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus - Majumder - 2021 - Advanced Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/15377b4c-be71-480b-a763-67baea14ff4c/adtp202000203-fig-0005-m.jpg)
Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus - Majumder - 2021 - Advanced Therapeutics - Wiley Online Library
![Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery - Vaughan - 2020 - Advanced Materials - Wiley Online Library Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery - Vaughan - 2020 - Advanced Materials - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d4aa3108-bdd6-4865-a6a6-a02697bc0cd8/adma201901081-fig-0003-m.jpg)
Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery - Vaughan - 2020 - Advanced Materials - Wiley Online Library
Lin28a Regulates Pathological Cardiac Hypertrophic Growth Through Pck2-Mediated Enhancement of Anabolic Synthesis
![Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus - Majumder - 2021 - Advanced Therapeutics - Wiley Online Library Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus - Majumder - 2021 - Advanced Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cfebb77e-f1d2-42e3-a55e-4cda824389e6/adtp202000203-fig-0001-m.jpg)
Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus - Majumder - 2021 - Advanced Therapeutics - Wiley Online Library
![Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice: Molecular Therapy - Nucleic Acids Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/639a6fae-4405-4aa2-8117-ad60a2c797e6/gr1.jpg)
Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice: Molecular Therapy - Nucleic Acids
![Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice: Molecular Therapy - Nucleic Acids Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/c934cecc-abba-4173-9484-419a9e8c08bc/fx1.jpg)
Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice: Molecular Therapy - Nucleic Acids
![Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies: Molecular Therapy - Nucleic Acids Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/14a79370-f6b3-475d-9389-dc393e2193de/fx1_lrg.jpg)
Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies: Molecular Therapy - Nucleic Acids
![Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy | Science Translational Medicine Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aag0481/asset/ddac10b1-84b1-4d3c-b041-1cd2337c212a/assets/graphic/aag0481-f2.jpeg)